Biopharmaceutical Company Puma Biotechnology
About Puma Biotechnology
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, California. The company focuses on the development and commercialization of innovative drug candidates that are undergoing or have already completed initial clinical studies.
Recent News
Phase II Trial for Extensive Stage Small Cell Lung Cancer
Puma Biotechnology recently announced the initiation of a Phase II trial for the treatment of extensive stage small cell lung cancer. The trial, known as Study PUMA-ALI-4201, will enroll up to 60 patients who have progressed after previous treatment. The study will evaluate the safety and efficacy of Puma's lead drug candidate, PUMA-ALI-4201, in combination with standard chemotherapy.
Comments